Itamar Medical Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 13.57 million compared to USD 11 million a year ago. Net loss was USD 7.98 million compared to USD 2.76 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. For the nine months, sales was USD 38.1 million compared to USD 28.26 million a year ago. Net loss was USD 18.25 million compared to USD 8 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.02 a year ago.